Verrica Pharmaceuticals Reports Second Quarter 2025 Financial Results

Go back to Verrica Pharmaceuticals Reports Second Quarter 2025 Financial Results
(NASDAQ: VRCA) Delayed: 5.39 +0.15 (2.86%)
Previous Close $5.24    52 Week High
Open $5.32    52 Week Low
Day High $5.56    P/E N/A 
Day Low $5.32    EPS
Volume 8,812